Stephanie Hoppe
Overview
Explore the profile of Stephanie Hoppe including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
401
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mangiardi-Veltin M, Chammings F, Jaffre A, Rousvoal A, Tunon de Lara C, Brouste V, et al.
Bull Cancer
. 2021 Sep;
108(11):999-1009.
PMID: 34556291
Introduction: Women identified as high-risk for breast cancer may choose between close follow-up and radical mastectomy. Prophylactic mastectomy, as any other surgery, is associated with benefits and harms. The aim...
2.
Boisserie-Lacroix M, Doutriaux-Dumoulin I, Chopier J, Boyer B, Depetiteville M, Hoppe S, et al.
Eur Radiol
. 2021 Apr;
31(10):7783-7791.
PMID: 33846843
Objectives: To evaluate the diagnostic accuracy of breast MRI in identifying lesions requiring excision for patients with suspicious nipple discharge but normal mammograms and ultrasounds. Methods: Between September 2013 and...
3.
Ratzmann A, Welk A, Hoppe S, Fanghaenel J, Schwahn C
Head Face Med
. 2020 Dec;
16(1):37.
PMID: 33323128
Background: The aim of the study was to compare a 2D and 3D color system concerning a variety of statistical and graphical methods to assess validity and reliability of color...
4.
Pinard C, Debled M, Ben Rejeb H, Velasco V, Tunon de Lara C, Hoppe S, et al.
Breast Cancer Res Treat
. 2019 Sep;
179(1):11-23.
PMID: 31529299
Purpose: There is a need to refine the prognosis of triple-negative breast cancer (TNBC) patients after neoadjuvant chemotherapy (NAC) and to study the influence of the tumor microenvironment. We evaluated...
5.
Bonsack M, Hoppe S, Winter J, Tichy D, Zeller C, Kupper M, et al.
Cancer Immunol Res
. 2019 Mar;
7(5):719-736.
PMID: 30902818
Knowing whether a protein can be processed and the resulting peptides presented by major histocompatibility complex (MHC) is highly important for immunotherapy design. MHC ligands can be predicted by peptide-MHC...
6.
Laurent E, Begueret H, Bonhomme B, Veillon R, Thumerel M, Velasco V, et al.
Am J Surg Pathol
. 2019 Jan;
43(3):293-302.
PMID: 30628926
Triple-negative breast cancer (TNBC) patients have an increased risk of developing visceral metastases and other primary nonbreast cancers, particularly lung cancer. The differential diagnosis of TNBC metastases and primary cancers...
7.
Blatnik R, Mohan N, Bonsack M, Falkenby L, Hoppe S, Josef K, et al.
Proteomics
. 2018 Apr;
18(11):e1700390.
PMID: 29603667
For rational design of therapeutic vaccines, detailed knowledge about target epitopes that are endogenously processed and truly presented on infected or transformed cells is essential. Many potential target epitopes (viral...
8.
Steinbach A, Winter J, Reuschenbach M, Blatnik R, Klevenz A, Bertrand M, et al.
Oncoimmunology
. 2017 Aug;
6(7):e1336594.
PMID: 28811980
Immune evasion of tumors poses a major challenge for immunotherapy. For human papillomavirus (HPV)-induced malignancies, multiple immune evasion mechanisms have been described, including altered expression of antigen processing machinery (APM)...
9.
Bobin M, Zacharatou C, Sargos P, Brouste V, Lisbona A, Mahe M, et al.
Radiat Oncol
. 2017 Feb;
12(1):32.
PMID: 28143487
Purpose: To evaluate the efficacy and toxicity of helical tomotherapy (HT) in the management of spine chordomas when proton therapy is unavailable or non-feasible. Methods And Materials: Between 2007 and...
10.
Dekhtiarenko I, Ratts R, Blatnik R, Lee L, Fischer S, Borkner L, et al.
PLoS Pathog
. 2016 Dec;
12(12):e1006072.
PMID: 27977791
Cytomegalovirus (CMV) elicits long-term T-cell immunity of unparalleled strength, which has allowed the development of highly protective CMV-based vaccine vectors. Counterintuitively, experimental vaccines encoding a single MHC-I restricted epitope offered...